Sponsor pipeline

Shanghai Zhimeng Biopharma, Inc. clinical trial pipeline

Get alerts when Shanghai Zhimeng Biopharma, Inc.'s trials change

4 active trials 3 recruiting 2 Phase 3 2 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-23
critical
NCT06612775 A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients… · Phase 2
2026-09-23
notable
NCT07082192 A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult… · Phase 2/3

Active trials by phase

Phase 2
2
Phase 2/3
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07095855 A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB Chronic Hepatitis B Not Yet Recruiting 2025-08-03
Phase 2/3
NCT07082192 A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult… ALS (Amyotrophic Lateral Sclerosis) Recruiting 2026-09-22
Phase 2
NCT06612775 A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients… Focal Epilepsy Recruiting 2026-09-22
NCT07238868 An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in… Focal Epilepsy Recruiting 2025-11-20

Disease areas by active trials

Get alerts when Shanghai Zhimeng Biopharma, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free